| 1. |
?Lakhani S, Ellis I, Schnitt S, et al. WHO classification of tumours of the breast. 4th ed. Lyon:IARC Press, 2012:2-14.
|
| 2. |
Tavassoli FA, Devilee P. Pathology and genetics of tumours of the breast and female genital organs. Lyon:IARC Press, 2003:10-112.
|
| 3. |
Costarelli L, Campagna D, Mauri M, et al. Intraductal proliferative lesions of the breast-terminology and biology matter:premalignant lesions or preinvasive cancer?. Int J Surg Oncol, 2012, 2012:501904.
|
| 4. |
Kabat GC, Jones JG, Olson N, et al. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control, 2010, 21(6):821-828.
|
| 5. |
Page DL, Schuyler PA, Dupont WD, et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk:a retrospective cohort study. Lancet, 2003, 361(9352):125-129.
|
| 6. |
Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med, 2005, 353(3):229-237.
|
| 7. |
Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer:an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med, 1998, 122(12):1053-1055.
|
| 8. |
Javid SH, Fang LC, Korde L, et al. Renaming ductal carcinoma in situ:would removing "carcinoma" reduce overtreatment?. J Natl Compr Canc Netw, 2014, 12(4):599-602.
|
| 9. |
Fritz AG. International classification of diseases for oncology:ICD-O. 3rd ed. Geneva:World Health Organization, 2000:850-854.
|
| 10. |
Page DL, Dupont WD, Rogers LW, et al. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer, 1985, 55(11):2698-2708.
|
| 11. |
American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York:Springer, 2010:420-440.
|
| 12. |
Prasad ML, Osborne MP, Giri DD, et al. Microinvasive carcinoma (T1mic) of the breast:clinicopathologic profile of 21 cases. Am J Surg Pathol, 2000, 24(3):422-428.
|
| 13. |
Mori M, Tsugawa K, Yamauchi H, et al. Pathological assessment of microinvasive carcinoma of the breast. Breast Cancer, 2013, 20(4):331-335.
|
| 14. |
Shatat L, Gloyeske N, Madan R, et al. Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics. Hum Pathol, 2013, 44(12):2684-2689.
|
| 15. |
Rakha EA, Aleskandarany M, El-Sayed ME, et al. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. Eur J Cancer, 2009, 45(10):1780-1787.
|
| 16. |
Rody A, Karn T, Liedtke C, et al. A clinically relevant gene signature in triple negative and basal-like breast cancer. Breast Cancer Res, 2011, 13(5):R97.
|
| 17. |
Lacroix-Triki M, Suarez PH, Mackay A, et al. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type. J Pathol, 2010, 222(3):282-298.
|
| 18. |
Toikkanen S, Kujari H. Pure and mixed mucinous carcinomas of the breast:a clinicopathologic analysis of 61 cases with long-term follow-up. Hum Pathol, 1989, 20(8):758-764.
|
| 19. |
Van Laere SJ, Van den Eynden GG, Van der Auwera I, et al. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Res Treat, 2006, 95(3):243-255.
|
| 20. |
Zell JA, Tsang WY, Taylor TH, et al. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC):analysis of 2014 IBC patient cases from the California Cancer Registry.Breast Cancer Res, 2009, 11(1):R9.
|
| 21. |
Hartman M, Czene K, Reilly M, et al.Incidence and prognosis of synchronous and metachronous bilateral breast cancer.J Clin Oncol, 2007, 25(27):4210-4216.
|
| 22. |
Huo D, Melkonian S, Rathouz PJ, et al.Concordance in histological and biological parameters between first and second primary breast cancers.Cancer, 2011, 117(5):907-915.
|
1/5
WeChat